Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margalida Rotger

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Pharmacogenetics and Genomics|February 25, 2009
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionJulia di Iulio, Aurélie Fayet, Mona Arab-Alameddine, et al.
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
Nature Communications|August 12, 2016
Identification of Siglec-1 null individuals infected with HIV-1Javier Martinez-Picado, Paul J McLaren, Itziar Erkizia, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsMona Arab-Alameddine, Aurélie Fayet-Mello, Rubin Lubomirov, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceJulia di Iulio, Angela Ciuffi, Karen Fitzmaurice, et al.
Pharmacogenetics and Genomics|November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsRubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 15, 2016
Privacy-preserving genomic testing in the clinic: a model using HIV treatmentPaul J McLaren, Jean Louis Raisaro, Manel Aouri, et al.
Nature Medicine|October 9, 2009
CCL3L1 and HIV/AIDS susceptibilityThomas J Urban, Amy C Weintrob, Jacques Fellay, et al.
The Journal of Clinical Investigation|May 11, 2011
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaqueMargalida Rotger, Judith Dalmau, Andri Rauch, et al.
Blood|December 17, 2013
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damageRuth Clifford, Tania Louis, Pauline Robbe, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Pharmacogenetics and Genomics|February 25, 2009
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionJulia di Iulio, Aurélie Fayet, Mona Arab-Alameddine, et al.
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
Nature Communications|August 12, 2016
Identification of Siglec-1 null individuals infected with HIV-1Javier Martinez-Picado, Paul J McLaren, Itziar Erkizia, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsMona Arab-Alameddine, Aurélie Fayet-Mello, Rubin Lubomirov, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceJulia di Iulio, Angela Ciuffi, Karen Fitzmaurice, et al.
Pharmacogenetics and Genomics|November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsRubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 15, 2016
Privacy-preserving genomic testing in the clinic: a model using HIV treatmentPaul J McLaren, Jean Louis Raisaro, Manel Aouri, et al.
Nature Medicine|October 9, 2009
CCL3L1 and HIV/AIDS susceptibilityThomas J Urban, Amy C Weintrob, Jacques Fellay, et al.
The Journal of Clinical Investigation|May 11, 2011
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaqueMargalida Rotger, Judith Dalmau, Andri Rauch, et al.
Blood|December 17, 2013
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damageRuth Clifford, Tania Louis, Pauline Robbe, et al.
Pageof 5